(Q37097096)
Statements
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity (English)
Siddha N Kasar
Laura Rassenti
Matthew S Davids
David C Fisher
Arnold S Freedman
Caron A Jacobson
Philippe Armand
Jeremy S Abramson
Jon E Arnason
Thomas J Kipps
Stacey Fernandes
John Hanna
1 reference
1 reference